Demographic data for all the treated patients
Treatment group | ||||
---|---|---|---|---|
25 mg BIIL 284 (n = 7) | 150 mg BIIL 284 (n = 9) | Placebo (n = 10) | Total (n = 26) | |
Sex, No (%) | ||||
Male | 0 (0) | 2 (22) | 4 (40) | 6 (23) |
Female | 7 (100) | 7 (78) | 6 (60) | 20 (77) |
Age (years), mean (SD) | 50.3 (14) | 55.3 (8.5) | 48.4 (13.5) | 51.3 (12.1) |
Height (cm), mean (SD) | 161.3 (8.3) | 167.4 (8.8) | 168.2 (9.6) | 166.1 (9.1) |
Weight (kg), mean (SD) | 77.39 (18.0) | 70.4 (13.7) | 66.5 (11.8) | 70.8 (14.4) |
Duration of disease (years), mean (SD) | 5.9 (3.8) | 7.8 (7.2) | 5.3 (5.4) | 6.3 (5.7) |
Rheumatoid factor positive, No (%) | 2 (29) | 4 (44) | 6 (60) | 12 (46) |